Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological insight to meaningful patient outcomes; multiple clinica ...

Abstract: Due to the wide dynamic range in real low-light scenes, there will be large differences in the degree of contrast degradation and detail blurring of captured images, making it difficult for ...

Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the ...

Abstract: In this article, the recursive filtering problem is investigated for a class of discrete-time stochastic dynamical networks where the data delivery from the sensors to the filter is ...

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.85, moving -3.27% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.33%. On ...

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $3.90, marking a -4.88% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.51% for ...

Imagine a computer program that doesn’t just do what it’s told, but actively looks at its own code, identifies weaknesses, and rewrites itself to be smarter. Then, with its newly increased ...